Furthermore, as GAD is highly expressed in pancreatic beta-cells, 30% of patients with SPS have type 1 diabetes mellitus (DM) among other associated conditions, including thyroiditis and vitiligo [9]. The gene discussed is GAD1; the disease is diabetes mellitus.